By David Vaczek, Senior Editor
With buy in from all pharma supply chain sectors, the RxTEC Act provides a model for automated lot-level tracking.
With the RxTEC Act, pharmaceutical supply chain members are proposing a phased-in approach to track-and-trace with a federal law imposing uniform requirements on all states.
rfXcel Corporation, the leading provider of production-proven ePedigree and Track and Trace Systems, today announced the rfXcel Traceability Portal, the first of its kind. The system is available immediately and has recently been deployed at over one thousand clinics nationwide.
Delta Air Lines has inked an exclusive marketing agreement with OnAsset Intelligence, a provider of machine-to-machine (M2M) wireless asset tracking solutions, enabling Delta Cargo customers to view GPS location information on deltacargo.com, Delta reported.
Users will be able to track and trace cargo in transit across the Delta and Delta Connection fleet, which operates more than 5000 daily flights to more than 340 destinations, 61 countries and six continents. Cargo status can be viewed on a customized Web page.
California’s State Board of Pharmacy (CA BoP) met this week to begin preparing for implementation of the state’s electronic pedigree requirements. CA BoP hosted Connie T. Jung, FDA’s acting associate director for policy and communications in the Center for Drug Evaluation and Research, who explained FDA's goals for a track and trace system. While CA BoP nor FDA did not issue any new policies or make any new decisions, the meeting revealed how closely these two are working together.
By Marie Redding
It’s increasingly difficult—even for the experts—to tell the difference between a counterfeit drug and the real thing. Consumers feel they have no sure way of knowing if they’re getting duped. They may even ingest a harmful ingredient a counterfeiter has used to make a fake pill—like highway paint, floor wax, and boric acid—according to a CBS news report.
Now in our archives is our exclusive virtual conference event that examines one of the key issues facing the Pharma and BioPharma supply chain, counterfeit drugs. Titled ‘Pharmaceutical Track & Trace and Authentication: The Fight against Fake Drugs’, the event is presented by UBM brands Pharmaceutical & Medical Packaging News, Tracking & Tracing Pharmaceutical Products, InnoPack, and Pharmapack in association with CPhI Conferences. The online format features two supplier webinars, two “exhibition halls” and a lineup of featured speakers.
ROC IT Solutions reports that a major pharmaceutical manufacturer has upgraded its implementation of ROC IT Solutions technology for track and trace in Turkey. The company's distribution center in Turkey first deployed ROC IT Solutions software in 2009 to meet the Turkish Ministry of Health (MoH) directive for item-level serialization and upgraded after its parent company began using a newer version of ROC IT solutions in the United States.
On Feb 15-16, FDA held a public workshop, “Determination of System Attributes for the Tracking and Tracing of Prescription Drugs,” which was attended by manufacturers, distributors, pharmacy representatives, government groups, and suppliers of software and technology.
In February 2011, the European Parliament adopted the “Falsified Medicines Directive.” The legislation is intended to protect EU citizens from falsified medicines, which are defined as products that “may contain ingredients in the wrong dosage or no active ingredients at all.” A distinction is made between “falsified medicines” and “counterfeit medicines,” which are defined as “medicines that do not comply with EU law on intellectual and industrial property rights, such as registered trademarks or patent rights.” According to a mem